In a phase 2b trial, nearly 100% of patients treated with SAP-001 at the 30mg and 60mg doses achieved the target serum uric acid level of less than 6mg/dL. The Food and Drug Administration (FDA) has ...

AR882 is an investigational selective uric acid transporter 1 inhibitor. The Food and Drug Administration (FDA) has granted Fast Track designation to AR882 for the treatment of clinically visible ...

TikTok is overflowing with videos promising to “flush” uric acid, reverse gout overnight, or cure joint pain with a single kitchen ingredient. For people living with the stabbing agony of a gout flare ...

Prolonged hyperuricemia is a major risk factor for gout, which is now regarded as a curable disease. Awareness of the various factors that can trigger gout flares is essential for their prevention. An ...